X
Record #23427

Updated Overall Survival and Final Progression-Free Survival Data for Patients With Treatment-Naïve Advanced ALK-positive Non-Small-Cell Lung Cancer in the ALEX Study

Publisher
Elsevier
Original paper date
May 11, 2020
Institution
State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, NT, Hong Kong · University of Colorado, Denver, CO, USA · Department of Internal Medicine, Rogel Cancer Center/University of Michigan, Ann Arbor, MI, USA · Catalan Institute of Oncology, Barcelona, Spain · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland · Seoul National University Hospital, Seoul, South Korea · Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France · Chao Family Comprehensive Cancer Center, University of California, Irvine, CA, USA · Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea · Massachusetts General Hospital, Boston, MA, USA · F. Hoffmann-La Roche Ltd, Basel, Switzerland · Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
Open access
No
Broad categories
(HSC) Biostatistics/Epidemiology(HSC) Medicine - Oncology(HSC) Medicine - Pulmonology
Notes from Retraction Watch

article retracted and reinstated unknown date/reasons (1/29/22 AJA)

Citation lifecycle

How this paper is being cited

Pre-retraction
0
Same day
0
Post-retraction
571
% post-retraction
100.4%
~89.9 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse